| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6C9UKZ0CYE |
| InChI Key | MBKYLPOPYYLTNW-ZDUSSCGKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H18FN3O5 |
| Molecular Weight | 399.38 |
| AlogP | 1.7 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 96.97 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | Mineralocorticoid receptor modulator | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 1
|
- | - | - | 2512 | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 2
|
13 | 316-398 | - | 40 | 90-109 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Heart Failure | 1 | D006333 | ClinicalTrials |
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3916929 |
| DrugBank | DB15418 |
| FDA SRS | 6C9UKZ0CYE |
| Guide to Pharmacology | 11281 |
| PDB | ECV |
| PubChem | 118599727 |
| SureChEMBL | SCHEMBL17363859 |